Kenneth J. Hillan - 20 May 2023 Form 4 Insider Report for 23andMe Holding Co. (MEHCQ)

Role
Chief Therapeutics Officer
Signature
/s/ Kenneth Hillan, by Kathy Hibbs, attorney-in-fact
Issuer symbol
MEHCQ
Transactions as of
20 May 2023
Net transactions value
-$8,978
Form type
4
Filing time
23 May 2023, 16:05:47 UTC
Previous filing
22 Feb 2023
Next filing
05 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ME Class A Common Stock Tax liability $8,978 -4,628 -2.3% $1.94 192,842 20 May 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The closing price on May 19, 2023, the fair market value used for the transaction date.
F2 Includes 5,765 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on February 28, 2023.